Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.26

+1.2%

Nov 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robohogs who wrote (9052)	9/8/2003 10:44:17 AM
From: Biomaven	Read Replies (3) of 52153

short techs and go long drugs. Nah, I don't think so It's worth talking some about the macro environment here. I view real-estate refinancings as having been a huge driver of consumer spending over the last few years. I think that party is now very much over - the sharp uptick in rates will cool off (or maybe even in some areas reverse) real estate appreciation and also sharply limit further refinancing. On the other hand, business spending seems to be picking up. Today's WSJ has a front-page article showing that the capacity glut in many sectors is slowly ebbing. So perhaps the correct play for the next months (or longer) may be long tech (including biotech) and short consumer and real-estate stocks. Interesting that WMT is down today (despite saying that they are on-track for September sales gains of 3-5%)amidst a good day for tech and biotech. Bonds and the dollar remain extremely unclear to me. Comments welcomed. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next